☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
febrile neutropenia
Sandoz's Ziextenzo (biosimilar- pegfilgrastim) Receives the US FDA's Approval to Decrease the Incidence of Febrile Neutropenia
November 5, 2019
Coherus Biosciences' Udenyca (Pegfilgrastim Biosimilar) Receives EU Marketing Approval for Febrile Neutropenia
September 26, 2018
Sandoz's Biosimilar Pegfilgrastim Receives CHMP Approval for Febrile Neutropenia
September 21, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.